NRG GU006

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Genitourinary, Prostate, Prostate Recurrent

Status:

Temporarily Closed

A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or Without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer

NCT#03371719

NRG-GU006 will temporarily close to Step 1 accrual at 5PM EST February 3, 2020, because it has potentially reached its accrual target, based on Pam50 molecular subtype accruals and patients registered to Step 1.